Objective The aim of this study was to evaluate for 12 months the changes of body weight using Depot Medroxyprogesterone Acetate (DMPA) and if these changes are related to inflammatory markers. Subjects and methods Twenty women of childbearing age who chose the DMPA, without previous use of this method, BMI < 30 kg/m2, and 17 women using IUD TCu 380A, participated in the study. At the baselin...

Women are always afraid about weight and some of them report weight changes after started a hormonal contraceptive. A recent Cochrane’s review affirmed that it is a patient misperceived perception. The review analyzed effects of progestogen-only contraceptive methods (implants, LNG-IUS, oral progesteroneonly and depot medroxyprogesterone acetate-DMPA) on weight and found limited scientific evid...

We examined the association between host factors present near the time of human immunodeficiency virus type 1 (HIV-1) acquisition and subsequent virus loads, in a prospective cohort study of women in Mombasa, Kenya. Women were prospectively followed monthly before HIV-1 infection. One hundred sixty-one commercial sex workers who became infected with HIV-1 were followed for a median of 34 months...

OBJECTIVE AND DESIGN Some studies suggest that specific hormonal contraceptive methods [particularly depot medroxyprogesterone acetate (DMPA)] may increase women's HIV acquisition risk. We updated a systematic review to incorporate recent epidemiological data. METHODS We searched for articles published between 15 January 2014 and 15 January 2016 and hand-searched reference lists. We identifie...

The 2002 National Survey of Family Growth reported that 5.3% of all US women aged 15 through 44 currently using contraception used DMPA.1 Among contraceptors, 13.9% of those aged 15 to 19 and 10.1% of those aged 20 to 24 currently used DMPA compared with 1.6% of those aged 40 to 44.1 Decreasing rates of adolescent pregnancy between 1995 and 2002 are considered to be due in part to increased use...

OBJECTIVE To assess the risk of venous thrombosis associated with nonoral contraceptives (ie, injectable depot-medroxyprogesterone acetate contraceptives, hormone [levonorgestrel]-releasing intrauterine devices, a contraceptive patch, or a contraceptive implant). METHODS AND RESULTS Analyses were performed in the Multiple Environmental and Genetic Assessment study, a large case-control study ...

The biggest use of contraceptives in Indonesia is 3-month injectable contraceptives, 3- month containing Depo Medroxyprogesterone acetate (DMPA) where long-term DMPA contraception results sex hormone deficiency so that the acceptor experiences sexual dysfunction aspects desire (libido) and intercourse pain. purpose this study was to analyze relationship between long hormonal with incidence acce...